Showing results (21-30 of 45) with videos related to

Sort By:
Pageof 5
Diagnostic Microbiology and Infectious Disease|March 1, 2015
Surrogate analysis of vancomycin to predict susceptible categorization of dalbavancinRonald N Jones, David J Farrell, Robert K Flamm, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 7, 2022
Sulopenem for the Treatment of Complicated Urinary Tract Infections Including Pyelonephritis: A Phase 3, Randomized TrialMichael W Dunne, Steven I Aronin, Anita F Das, et al.
The Journal of Antimicrobial Chemotherapy|November 1, 2015
Efficacy of dalbavancin in the treatment of MRSA rat sternal osteomyelitis with mediastinitisYoav Barnea, Anat Lerner, Asaf Aizic, et al.
Journal of Global Antimicrobial Resistance|February 24, 2019
Single-dose dalbavancin and patient satisfaction in an outpatient setting in the treatment of acute bacterial skin and skin structure infectionsUrania Rappo, Pedro L Gonzalez, Sailaja Puttagunta, et al.
The Journal of Biological Chemistry|November 18, 2006
In vitro efficacy, resistance selection, and structural modeling studies implicate the malarial parasite apicoplast as the target of azithromycinAmar Bir Singh Sidhu, Qingan Sun, Louis J Nkrumah, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 7, 2022
Sulopenem or Ciprofloxacin for the Treatment of Uncomplicated Urinary Tract Infections in Women: A Phase 3, Randomized TrialMichael W Dunne, Steven I Aronin, Anita F Das, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|November 4, 2024
A phase 3 randomized trial of sulopenem vs. ertapenem in patients with complicated intra-abdominal infectionsMichael W Dunne, Steven I Aronin, Anita F Das, et al.
BMC Infectious Diseases|December 19, 2024
Replacing serum with dried blood microsampling for pharmacokinetics, viral neutralisation and immunogenicity bioanalysis supporting future paediatric development of RSM01, a candidate respiratory syncytial virus neutralising monoclonal antibodyJoleen T White, Jonne Terstappen, Micha Levi, et al.
Thrombosis and Haemostasis|November 23, 2023
Antithrombotic Prophylaxis with Rivaroxaban in Patients with Prehospital COVID-19: A Meta-analysis of Two Placebo-Controlled TrialsJudith Hsia, Alex C Spyropoulos, Gregory Piazza, et al.
Infectious Diseases and Therapy|January 30, 2021
Safety of Dalbavancin in the Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI): Nephrotoxicity Rates Compared with Vancomycin: A Post Hoc Analysis of Three Clinical TrialsPedro L Gonzalez, Urania Rappo, Veronica Mas Casullo, et al.
Pageof 5